[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569794":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":34,"responsibleParty":85,"collaborators":87,"id":91,"slug":92,"hasResults":93,"nctId":94,"briefTitle":95,"officialTitle":96,"acronym":97,"eligibilityCriteria":98,"healthyVolunteers":93,"sex":99,"minAge":100,"maxAge":19,"enrollmentInfo":101,"targetDuration":19,"studyType":104,"phases":105,"briefSummary":107,"conditions":108,"keywords":111,"overallStatus":116,"whyStopped":19,"lastUpdateSubmitDate":117,"lastUpdatePostDateStruct":118,"startDateStruct":121,"completionDateStruct":123,"leadSponsor":125,"locationsCount":126},{"fullName":5,"class":6},"Changhai Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"group of participants","EXPERIMENTAL","Patients with antiplatelet drugs-related acute non-hematochezia gastrointestinal bleeding are enrolled. All enrolled participants will undergo the examination of detachable string magnetically controlled capsule endoscopy (ds-MCE) first, followed by EGD within 24 hours.",[13],"Other: ds-MCE and EGD examinations",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"ds-MCE and EGD examinations","Sequentially performing ds-MCE and EGD examinations on enrolled participants.",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Zhuan Liao","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":19,"email":29},"Yizhi Chen","CONTACT","+8613761667311","chenyizhiyz@163.com",{"name":31,"role":27,"phone":32,"phoneExt":19,"email":33},"Xi Jiang, PhD","+8613127952352","jiangxi_stella@126.com",[35,51,62,72],{"facility":36,"status":19,"city":37,"state":19,"zip":19,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Qinghai Special Hospital of Cardio-Cerebrovascular Disease","Qinghai","China","CN",{"type":41,"coordinates":42},"Point",[43,44],106.075,25.80833,{"lat":44,"lon":43},[47],{"name":48,"role":27,"phone":49,"phoneExt":19,"email":50},"Xueqin Ma","+8613519735091","qhmaxueqin@126.com",{"facility":5,"status":19,"city":52,"state":19,"zip":19,"country":38,"countryCode":39,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Shanghai",{"type":41,"coordinates":54},[55,56],121.45806,31.22222,{"lat":56,"lon":55},[59],{"name":22,"role":27,"phone":60,"phoneExt":19,"email":61},"+8613061921980","zhuanleo@126.com",{"facility":63,"status":19,"city":52,"state":19,"zip":19,"country":38,"countryCode":39,"cosmosGeoPoint":64,"geoPoint":66,"contacts":67},"Shanghai East Hospital, Tongji University School of Medicine",{"type":41,"coordinates":65},[55,56],{"lat":56,"lon":55},[68],{"name":69,"role":27,"phone":70,"phoneExt":19,"email":71},"Meidong Xu","021-38804518","xumeidongeh@126.com",{"facility":73,"status":19,"city":74,"state":19,"zip":19,"country":38,"countryCode":39,"cosmosGeoPoint":75,"geoPoint":79,"contacts":80},"First Affiliated Hospital Xi'an Jiaotong University","Xi'an",{"type":41,"coordinates":76},[77,78],108.92861,34.25833,{"lat":78,"lon":77},[81],{"name":82,"role":27,"phone":83,"phoneExt":19,"email":84},"Shuixiang He","40000003222","hesx123@126.com",{"type":23,"investigatorFullName":22,"investigatorTitle":86,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Professor",[88,89],{"name":73,"class":6},{"name":90,"class":6},"Qilu Hospital of Shandong University","100569794","mce-identifying-bleeding-lesions-in-patients-with-antiplatelet-drugs-related-acute-non-hematochezia-gastrointestinal-bleeding-100569794",false,"NCT06698874","MCE Identifying Bleeding Lesions in Patients with Antiplatelet Drugs-Related Acute Non-Hematochezia Gastrointestinal Bleeding","Diagnostic Efficacy of Magnetically Controlled Capsule Endoscopy (MCE) for Identification of Bleeding Lesions in Patients with Antiplatelet Drugs-Related Acute Non-Hematochezia Gastrointestinal Bleeding：Prospective, Multicenter Study","MCE","Inclusion Criteria:\n\n1. No gender limit, age ≥ 18 years；\n2. Acute non-hematochezia gastrointestinal bleeding symptoms, including haematemesis or melena；\n3. Taking antiplatelet drugs continuously for at least 14 days；\n4. Hemodynamically stable；\n5. Able to provide informed consent.\n\nExclusion Criteria:\n\n1. Age \\\u003C 18 years；\n2. Hemodynamically unstable even after initial volume resuscitation and\u002For have ongoing fresh hematemesis at presentation；\n3. With upper gastrointestinal bleeding caused by peptic ulcer or acute gastric mucosal lesion within 1 month before inclusion；\n4. History of endoscopic therapy (such as ESD, EMR, etc.) within 1 month before inclusion；\n5. Gastrointestinal tumor, decompensation of cirrhosis with esophageal or gastric varices；\n6. Haematopathy and bleeding tendency；\n7. Patients who have no surgical conditions or refuse to undergo any abdominal surgery (once the capsule is stuck, it cannot be removed surgically)；\n8. Pacemaker or other implanted electromedical devices which could interfere with magnetic resonance；\n9. Patients plan to undergo magnetic resonance imaging examination before excretion of the capsule；\n10. Suspected or known intestinal stenosis or other known risk factors for capsule retention.\n11. Pregnancy；\n12. Dysphagia；\n13. With and conditon contraindicated to ds-MCE or EGD；\n14. With and conditon that is not suitable for participation in the study evaluated by researchers.","ALL","18 Years",{"count":102,"type":103},204,"ESTIMATED","INTERVENTIONAL",[106],"NA","The goal of this clinical trial is to explore the diagnostic efficacy of detachable string magnetically controlled capsule endoscopy (ds-MCE) for identification of bleeding lesions in patients with antiplatelet drugs-related acute non-hematochezia gastrointestinal bleeding. The main questions it aims to answer are:\n\nCompared to the conventional esophagogastroduodenoscopy, does ds-MCE accurately detect bleeding lesions in the upper gastrointestinal tract in patients with antiplatelet drugs-related acute non-hematochezia gastrointestinal bleeding? Recording bleeding lesions in the small bowel detected by ds-MCE in patients with antiplatelet drugs-related acute non-hematochezia gastrointestinal bleeding.\n\nParticipants will:\n\nUndergo ds-MCE first and subsequently EGD within 24 hours. Receive follow-up in the following 30days.",[109,110],"Gastrointestinal Bleeding","Antiplatelet Therapy",[112,113,114,115],"magnetically controlled capsule endoscopy","string","antiplatelet drugs","gastrointestinal bleeding","NOT_YET_RECRUITING","2024-11-20",{"date":119,"type":120},"2024-11-21","ACTUAL",{"date":122,"type":103},"2024-12-01",{"date":124,"type":103},"2026-12-30",{"name":5,"class":6},4]